Psychedelics Investing

Discussion surrounding science, industry and psychedelics reform is experiencing an all-time high, and 2024 promises to not only continue but further this trend.  In 2023, the psychedelics market saw transformative expansion driven by favorable trial outcomes, attracting significant investments...

Psilocybin-Assisted Therapy Achieves Positive Clinical Trial Results For Treating Generalized Anxiety Psilocybin-assisted therapy has hit a milestone as clinical trial results show potential benefits for Generalized Anxiety Disorder (GAD.)  With variable symptoms, the condition typically...

Welcome to a new episode of our Benzinga Psychedelics Podcast, this time joined by business trendspotter and "psychedelics concierge" Zappy Zapolin. He has served in a range of positions, from advisor to psychedelic companies like KetaMD – acquired by Braxia Scientific (OTC:BRAXF) and chief...

Welcome to Benzinga's weekly psychedelics headlines roundup. This is our pick of must-read news items from the second week of January 2024.  See previous edition: Psychedelics Headlines: Magic Mushrooms For Sexual Wellbeing, The DEA's Stance, The Therapist's Role & More...

Psychedelics Developer Secures $100M In Series A Funding, Will Support MDMA Approval To Treat PTSD A decade after it was founded as a wholly-owned subsidiary of the Multidisciplinary Association for Psychedelic Studies (MAPS), MAPS Public Benefit Corporation has secured over $100 million in a...

The emerging psychedelics industry is expanding rapidly across the globe. With research demonstrating promising therapeutic potential for substances like psilocybin and MDMA to treat mental health conditions, this sector has attracted growing attention and investment.  Recent research data...

Biopharma and resources-pooling company Atai Life Sciences (NASDAQ: ATAI) has invested a total of $50 million in Beckley Psytech Ltd., a U.K.-based clinical-stage biotech advancing short-duration psychedelics for neuropsychiatric conditions. Following the investment -$40 million direct and an...

John Lennon Remembered 43 Years After His Murder In New York, Psychedelic Adventures & Enduring Legacy The world seemed to come to a momentary halt on December 8, 1980, when news that John Lennon was shot and killed as he approached his apartment building in New York City came out. Lennon...

Cybin Officially Owns Small Pharma, Gets Three New International Patents Granted Psychedelics companies Cybin Inc. (NYSE: CYBN) and Small Pharma Inc. (OTCMKTS: DMTTF) have completed their August acquisition agreement. Following their arrangement plan under the BC Business Corporations Act, and...

Psychedelics biopharma company Cybin Inc. (NYSE: CYBN) shared its financial results for the fiscal year ended this March 31 as well as recent business highlights. Numbers show: Total cash of $12.5 (CA$16.6) million by March 31, 2023. Quarterly net loss of $10.3 million compared to $13.6 million...

Science Conference In Dubai, UAE Hosts Discussion On Psychedelics Research A milestone in psychedelics education was achieved: The Energia Foundation, organizer of the same conversation within this January’s WEF-parallel Davos House of Health, is taking education on the new therapeutics to...

Microdosing LSD For Major Depression Treatment Seeks Further Clinical Validation Via New Study Australian psychedelics company MindBio Therapeutics Corp. was granted approval by both the Ethics committee and the Clinical Trials Registry to begin the world's first Phase 2a take-home LSD...

In the current psychedelics landscape, one of the most important topics is compound legality.  While it's possible that MDMA-assisted therapy will eventually be federally approved in the U.S., what should investors consider when looking at a prospective business? The 2023 edition of...

MDMA Therapy For PTSD Nearing Legalization In U.S. And Worldwide, MAPS Releases Promising Data MAPS Public Benefit Corporation shared positive topline results from an observational follow-up of its two Phase 3 studies on the long-term safety and efficacy of MDMA-assisted therapy for PTSD.  The...

As part of the recent so-called “psychedelics renaissance,” numerous celebrities, global leaders and athletes are speaking out about their experiences with these substances. Their stories about the benefits and nuances are now part of an ongoing...